YOU ARE LEAVING THE SITE
You are now leaving the site and moving to an external website independently operated and not managed by GSK. GSK assumes no responsibility for the site. If you do not wish to leave the site, click “Cancel.”
SELECT A CATEGORY
Our condition overview covers the causes, signs and symptoms behind upper respiratory health issues. We also break down the gold standard guidelines on management.
Allergic rhinitis is a global health problem, affecting up to 20% of people globally.1
For people with allergies, persistent or repetitive exposure to allergens, which are typically innocuous substances, results in chronic allergic inflammation.2
Join the Community.
Click here to register
Patient care resources
Learning Lab resources
REPORT ADVERSE EVENT
This channel is intended for Healthcare Professionals, and those working under their Supervision, in the Republic of Ireland Only.
© 2021 GSK group of companies or its licensor. Trade marks are owned by or licensed to the GSK group of companies. GlaxoSmithKline Consumer Healthcare (Ireland) Limited is a private limited company registered in Ireland, with company number 24797 and registered office 12 Riverwalk, CityWest Business Campus, Dublin 24, Ireland.